WHO E-B (2019) WHO classification of tumours, Breast tumours 5th Edition: IARC Press; 2019

Kim J, Geyer FC, Martelotto LG, Ng CK, Lim RS, Selenica P et al (2018) MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene. J Pathol. 244(2):143–50

Article  PubMed  Google Scholar 

Martelotto LG, De Filippo MR, Ng CK, Natrajan R, Fuhrmann L, Cyrta J et al (2015) Genomic landscape of adenoid cystic carcinoma of the breast. J Pathol. 237(2):179–89

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwartz CJ, Brogi E, Marra A, Da Cruz Paula AF, Nanjangud GJ, da Silva EM et al (2022) The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features. Mod Pathol. 35(2):193–201

Article  CAS  PubMed  Google Scholar 

Trihia HJ, Valavanis C, Novkovic N, Koutsodontis G, Petraki M, Efstathiou E (2020) Polymorphous adenocarcinoma of the breast-an exceptionally rare entity: clinicopathological description of a case and brief review. Breast J. 26(2):261–4

Article  PubMed  Google Scholar 

Sebastiao APM, Pareja F, Kumar R, Brown DN, Silveira C, da Silva EM et al (2019) Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma. Histopathology. 75(2):193–201

Article  PubMed  Google Scholar 

Cima L, Kaya H, Marchio C, Nishimura R, Wen HY, Fabbri VP et al (2022) Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses. Virchows Arch. 480(1):109–26

Article  CAS  PubMed  Google Scholar 

Christgen M, Bartels S, Radner M, Raap M, Rieger L, Christgen H et al (2019) ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling. Genes Chromosomes Cancer. 58(3):175–85

Article  CAS  PubMed  Google Scholar 

Ross JS, Wang K, Sheehan CE, Boguniewicz AB, Otto G, Downing SR et al (2013) Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations. Clin Cancer Res. 19(10):2668–76

Article  CAS  PubMed  Google Scholar 

AGO German Commission Breast, State of art guidelines 2023 [Internet]. 2023. Available from: https://www.ago-online.de/en/leitlinien-empfehlungen/leitlinien-empfehlungen/kommission-mamma. Accessed 08.11.2023

Cancer NGB. NCCN guidelines breast cancer 2023 [Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419. Accessed 08.11.2023

Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2021) S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4. Mai

[Internet]. https://www.awmf.org/uploads/tx_szleitlinien/032-045OLl_S3_Mammakarzinom_2021-07.pdf. 2021. Available from: https://www.awmf.org/uploads/tx_szleitlinien/032-045OLl_S3_Mammakarzinom_2021-07.pdf. Accessed 08.11.2023

Cimino-Mathews A (2021) Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls. Mod Pathol. 34(Suppl 1):62–77

Article  CAS  PubMed  Google Scholar 

Bell D, Ferrarotto R, Liang L, Goepfert RP, Li J, Ning J et al (2020) Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland. Virchows Arch. 476(2):295–305

Article  CAS  PubMed  Google Scholar 

Toll A, Joneja U, Palazzo J (2016) Pathologic spectrum of secretory and mucinous breast lesions. Arch Pathol Lab Med. 140(7):644–50

Article  PubMed  Google Scholar 

Mortensen L, Ordulu Z, Dagogo-Jack I, Bossuyt V, Winters L, Taghian A et al (2021) Locally recurrent secretory carcinoma of the breast with NTRK3 gene fusion. Oncologist. 26(10):818–24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pohlodek K, Meciarova I, Grossmann P, Martinek P, Kinkor Z (2019) Secretory carcinoma of the breast: a case report. Int J Surg Case Rep. 56:74–7

Article  PubMed  PubMed Central  Google Scholar 

Geyer FC, Berman SH, Marchio C, Burke KA, Guerini-Rocco E, Piscuoglio S et al (2017) Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family. Mod Pathol. 30(1):69–84

Article  CAS  PubMed  Google Scholar 

Fusco N, Sajjadi E, Venetis K, Ivanova M, Andaloro S, Guerini-Rocco E et al (2022) Low-risk triple-negative breast cancers: clinico-pathological and molecular features. Crit Rev Oncol Hematol. 172:103643

Article  PubMed  Google Scholar 

Memon RA, Prieto Granada CN, Wei S (2020) Clear cell papillary neoplasm of the breast with MAML2 gene rearrangement: clear cell hidradenoma or low-grade mucoepidermoid carcinoma? Pathol Res Pract. 216(10):153140

Article  CAS  PubMed  Google Scholar 

Pareja F, Da Cruz Paula A, Gularte-Merida R, Vahdatinia M, Li A, Geyer FC et al (2020) Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes. NPJ Breast Cancer. 6:20

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan M, Gilmore H, Harbhajanka A (2020) Mucoepidermoid carcinoma of the breast with MAML2 rearrangement: a case report and literature review. Int J Surg Pathol. 28(7):787–92

Article  PubMed  Google Scholar 

Murase R, Sumida T, Ishikawa A, Murase R, McAllister SD, Hamakawa H et al (2011) Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer. Int J Otolaryngol. 2011:187623

Article  PubMed  PubMed Central  Google Scholar 

Haefliger S, Muenst S, Went P, Bihl M, Dellas S, Weber WP et al (2020) Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report. Mol Biol Rep. 47(6):4917–21

Article  CAS  PubMed  Google Scholar 

Pareja F, da Silva EM, Frosina D, Geyer FC, Lozada JR, Basili T et al (2020) Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity. Mod Pathol. 33(6):1056–64

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trihia HJ, Lampropoulos P, Karelis L, Souka E, Galanopoulos G, Provatas I (2021) Tall cell carcinoma with reversed polarity: a case report of a very rare breast tumor entity and mini-review. Breast J. 27(4):369–76

Article  PubMed  Google Scholar 

Geyer FC, Pareja F, Weigelt B, Rakha E, Ellis IO, Schnitt SJ et al (2017) The spectrum of triple-negative breast disease: high- and low-grade lesions. Am J Pathol. 187(10):2139–51

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jassim M, Premalata CS, Okaly G, Srinivas C (2021) Tall cell carcinoma with reverse polarity of breast: report of a case with unique morphologic and molecular features. Turk Patoloji Derg. 37(2):183–8

PubMed  PubMed Central  Google Scholar 

Cserni G, Quinn CM, Foschini MP, Bianchi S, Callagy G, Chmielik E et al (2021) Triple-negative breast cancer histological subtypes with a favourable prognosis. Cancers (Basel). 13(22):5694

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rakha EA, Quinn CM, Foschini MP, Munoz Martin M, Dabbs DJ, Lakhani S et al (2021) Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management. Histopathology. 78(5):759–71

Article  PubMed  Google Scholar 

Wong W, Brogi E, Reis-Filho JS, Plitas G, Robson M, Norton L et al (2021) Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma. NPJ Breast Cancer. 7(1):96

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schnitt SJ, Fend F, Decker T (2022) Breast carcinomas of low malignant potential. Virchows Arch. 480(1):5–19

Article  PubMed  Google Scholar 

Victoor J, Bourgain C, Vander Borght S, Vanden Bempt I, De Rop C, Floris G (2020) Fibromatosis-like metaplastic carcinoma: a case report and review of the literature. Diagn Pathol. 15(1):20

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bataillon G, Fuhrmann L, Girard E, Menet E, Lae M, Capovilla M et al (2018) High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast. Histopathology. 73(2):273–83

Article  PubMed  Google Scholar 

Romanucci G, Mercogliano S, Carucci E, Lunardi M, Caneva A, Benassuti C et al (2021) Low-grade adenosquamous carcinoma of the breast: a review with focus on imaging and management. Acta Radiol Open. 10(4):20584601211013500

PubMed  PubMed Central  Google Scholar 

Rakha EA, Brogi E, Castellano I, Quinn C (2022) Spindle cell lesions of the breast: a diagnostic approach. Virchows Arch. 480(1):127–45

Article  PubMed  Google Scholar 

Sinn HP, Varga Z (2023) Triple-negative breast cancer : classification, current concepts, and therapy-related factors. Pathologie (Heidelb). 44(1):32–8

Article  PubMed  Google Scholar 

Varga Z, Sinn P, Lebeau A (2023) B3 lesions of the breast: histological, clinical, and epidemiological aspects : update. Pathologie (Heidelb). 44(1):5–16

Article  PubMed  PubMed Central  Google Scholar 

Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D et al (2023) NCCN guidelines(R) insights: breast cancer, version 4.2023. J Natl Compr Canc Netw. 21(6):594–608

Article